US1638511089
US1638511089
Chemours Company (The)
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 2.05B EUR | 3.09B EUR | 3.31B EUR | 1.77B EUR |
Enterprise Value | 5.53B EUR | 6.54B EUR | 7.14B EUR | 5.49B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 7.11x | -- | -- | -- |
Price to Sales | 0.35x | 0.53x | 0.57x | 0.4x |
Price to Book | -- | -- | 15.41x | 7.07x |
EV/Revenue | 0.95x | 1.13x | 1.23x | 1.24x |
EV/EBITDA | 11.41x | 20.69x | 19.72x | 25.54x |
Price to FCF (P/FCF) | 6.76x | 14.16x | 21.51x | 7.15x |
EV/FCF | 18.25x | 29.98x | 46.37x | 22.23x |
FCF Yield | 14.8% | 7.06% | 4.65% | 13.98% |